Synthesis, α‐glucosidase Inhibition, in silico Pharmacokinetic, and Docking Studies Of Thieno[2,3‐b]Quinoline‐Acetamide Derivatives as New Anti‐Diabetic Agents
暂无分享,去创建一个
H. Rastegar | M. Faramarzi | M. Mahdavi | M. Mohammadi‐Khanaposhtani | H. Hamedifar | B. Larijani | Y. Valizadeh | Somayeh Mojtabavi | S. Hosseini | Milad Noori | Navid Dastyafteh | M. Biglar | R. Mirzazadeh | Minoo Khalili Ghomi
[1] K. Zhu,et al. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation. , 2021, Bioorganic chemistry.
[2] B. Larijani,et al. Synthesis, in vitro and in silico enzymatic inhibition assays, and toxicity evaluations of new 4,5-diphenylimidazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors , 2021, Medicinal Chemistry Research.
[3] Abhishek Das,et al. An overview on the role of bioactive α-glucosidase inhibitors in ameliorating diabetic complications , 2020, Food and Chemical Toxicology.
[4] M. Snoussi,et al. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study. , 2020, Bioorganic chemistry.
[5] Chao-Yun Cai,et al. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion. , 2019, European journal of medicinal chemistry.
[6] N. Uddin,et al. Synthesis of quinoline derivatives as diabetic II inhibitors and molecular docking studies. , 2019, Bioorganic & medicinal chemistry.
[7] B. Larijani,et al. New Biscoumarin Derivatives as Potent α-Glucosidase Inhibitors: Synthesis, Biological Evaluation, Kinetic Analysis, and Docking Study , 2018, Polycyclic Aromatic Compounds.
[8] B. Larijani,et al. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. , 2018, Bioorganic chemistry.
[9] S. M. A. Hussaini. Therapeutic significance of quinolines: a patent review (2013-2015) , 2016, Expert opinion on therapeutic patents.
[10] H. Wahab,et al. Synthesis, In vitro and Docking Studies of New Flavone Ethers as α‐Glucosidase Inhibitors , 2016, Chemical biology & drug design.
[11] Syed Muhammad Kashif,et al. Synthesis of novel flavone hydrazones: in-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies. , 2015, European journal of medicinal chemistry.
[12] Hoi-Seon Lee,et al. Quinoline-2-carboxylic acid isolated from Ephedra pachyclada and its structural derivatives show inhibitory effects against α-glucosidase and α-amylase , 2014, Journal of the Korean Society for Applied Biological Chemistry.
[13] Y. Mabkhot,et al. Synthesis of Thieno[2,3-b]thiophene Containing Bis-Heterocycles-Novel Pharmacophores , 2013, International journal of molecular sciences.
[14] G. Derosa,et al. α-Glucosidase inhibitors and their use in clinical practice , 2012, Archives of medical science : AMS.
[15] R. Bye,et al. α-glucosidase inhibitors from Brickellia cavanillesii. , 2012, Journal of natural products.
[16] M. Pollastri,et al. Overview on the Rule of Five , 2010, Current protocols in pharmacology.
[17] Suresh Kumar,et al. Biological activities of quinoline derivatives. , 2009, Mini reviews in medicinal chemistry.
[18] Torsten Schwede,et al. The SWISS-MODEL Repository and associated resources , 2008, Nucleic Acids Res..
[19] R. Dwek,et al. Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles. , 2006, The Journal of general virology.
[20] M. Hanefeld,et al. Efficacy of α‐glucosidase inhibitors on lipids in NIDDM subjects with moderate hyperlipidaemia , 1994 .
[21] A. Kulkarni,et al. Quinoline containing benzimidazole and their biological activities , 2021, Current Trends in Pharmacy and Pharmaceutical Chemistry.